{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:21:01Z","timestamp":1783354861661,"version":"3.54.6"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"DOI":"10.1186\/s12896-026-01165-7","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:44:22Z","timestamp":1778600662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Affinity enhancement of an anti-VEGF humanized nanobody as a superior candidate to bevacizumab: integrative in silico and in vitro studies"],"prefix":"10.1186","volume":"26","author":[{"given":"Mir Salar","family":"Kazemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Shahriar","family":"Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Kazemi-Lomedasht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Ahangari Cohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Zandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Shoari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hosseininejad-Chafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnoosh","family":"Mahjoobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arghavan","family":"Ashja Ardalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1497-2260","authenticated-orcid":false,"given":"Mozhgan Rezaei","family":"Kanavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4839-5123","authenticated-orcid":false,"given":"Mahdi","family":"Behdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"4","key":"1165_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2003-0027","volume":"25","author":"N Ferrara","year":"2004","unstructured":"Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25(4):581\u2013611. https:\/\/doi.org\/10.1210\/er.2003-0027.","journal-title":"Endocr Rev"},{"issue":"5","key":"1165_CR2","doi-asserted-by":"publisher","first-page":"H2240","DOI":"10.1152\/ajpheart.2001.280.5.H2240","volume":"280","author":"X Yue","year":"2001","unstructured":"Yue X, Tomanek RJ. Effects of VEGF 165 and VEGF 121 on vasculogenesis and angiogenesis in cultured embryonic quail hearts. Am J Physiol Heart Circ Physiol. 2001;280(5):H2240\u20137. https:\/\/doi.org\/10.1152\/ajpheart.2001.280.5.H2240.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"1165_CR3","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.jbiotec.2006.11.027","volume":"128","author":"S Kim","year":"2007","unstructured":"Kim S, Mohamedali KA, Cheung LH, Rosenblum MG. Overexpression of biologically active VEGF121 fusion proteins in Escherichia coli. J Biotechnol. 2007;128(3):638\u201347. https:\/\/doi.org\/10.1016\/j.jbiotec.2006.11.027.","journal-title":"J Biotechnol"},{"issue":"1","key":"1165_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/1358836X0000500106","volume":"5","author":"J Dulak","year":"2000","unstructured":"Dulak J, J\u00f3zkowicz A, Ratajska A, Szuba A, Cooke JP, Dembi\u0144ska-Kie\u0107 A. Vascular endothelial growth factor is efficiently synthesized in spite of low transfection efficiency of pSG5VEGF plasmids in vascular smooth muscle cells. Vasc Med. 2000;5(1):33\u201340. https:\/\/doi.org\/10.1177\/1358836X0000500106.","journal-title":"Vasc Med"},{"issue":"4","key":"1165_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrc2346","volume":"8","author":"RK Jain","year":"2008","unstructured":"Jain RK. Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer. Nat Rev Cancer. 2008;8(4):309\u201316. https:\/\/doi.org\/10.1038\/nrc2346.","journal-title":"Nat Rev Cancer"},{"issue":"23","key":"1165_CR6","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"H Hurwitz","year":"2004","unstructured":"Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350(23):2335\u201342. https:\/\/doi.org\/10.1056\/NEJMoa032691.","journal-title":"N Engl J Med"},{"issue":"5","key":"1165_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrd1381","volume":"3","author":"N Ferrara","year":"2004","unstructured":"Ferrara N, Hillan KJ, Gerber H-P, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov. 2004;3(5):391\u2013400. https:\/\/doi.org\/10.1038\/nrd1381.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"1165_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1476-5381.2009.00190.x","volume":"157","author":"P Chames","year":"2009","unstructured":"Chames P, Van Regenmortel M, Weiss E, Baty D. Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol. 2009;157(2):220\u201333. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00190.x.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1165_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bioeng.2007.03.004","volume":"24","author":"D Filpula","year":"2007","unstructured":"Filpula D. Antibody engineering and modification technologies. Biomol Eng. 2007;24(2):201\u201315. https:\/\/doi.org\/10.1016\/j.bioeng.2007.03.004.","journal-title":"Biomol Eng"},{"issue":"14","key":"1165_CR10","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419\u201331. https:\/\/doi.org\/10.1056\/NEJMoa054481.","journal-title":"N Engl J Med"},{"key":"1165_CR11","unstructured":"Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function.pdf."},{"issue":"1","key":"1165_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00253-007-1142-2","volume":"77","author":"MM Harmsen","year":"2007","unstructured":"Harmsen MM, De Haard HJ. Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol. 2007;77(1):13\u201322. https:\/\/doi.org\/10.1007\/s00253-007-1142-2.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"1165_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1110\/ps.34602","volume":"11","author":"M Dumoulin","year":"2002","unstructured":"Dumoulin M, Conrath K, Van Meirhaeghe A, Meersman F, Heremans K, Frenken LGJ, et al. Single-domain antibody fragments with high conformational stability. Protein Sci. 2002;11(3):500\u201315. https:\/\/doi.org\/10.1110\/ps.34602.","journal-title":"Protein Sci"},{"issue":"28","key":"1165_CR14","doi-asserted-by":"publisher","first-page":"26285","DOI":"10.1074\/jbc.M102107200","volume":"276","author":"A Desmyter","year":"2001","unstructured":"Desmyter A, Decanniere K, Muyldermans S, Wyns L. Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody. J Biol Chem. 2001;276(28):26285\u201390. https:\/\/doi.org\/10.1074\/jbc.M102107200.","journal-title":"J Biol Chem"},{"issue":"1","key":"1165_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1128\/AEM.71.1.442-450.2005","volume":"71","author":"E Dolk","year":"2005","unstructured":"Dolk E, van der Vaart M, Lutje Hulsik D, Vriend G, de Haard H, Spinelli S, et al. Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo. Appl Environ Microbiol. 2005;71(1):442\u201350. https:\/\/doi.org\/10.1128\/AEM.71.1.442-450.2005.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"1165_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1472-6750-7-7","volume":"7","author":"A Olichon","year":"2007","unstructured":"Olichon A, Schweizer D, Muyldermans S, de Marco A. Heating as a rapid purification method for recovering correctly-folded thermotolerant VH and VHH domains. BMC Biotechnol. 2007;7(1):7. https:\/\/doi.org\/10.1186\/1472-6750-7-7.","journal-title":"BMC Biotechnol"},{"issue":"4","key":"1165_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10555-005-6193-1","volume":"24","author":"M Arbabi-Ghahroudi","year":"2005","unstructured":"Arbabi-Ghahroudi M, Tanha J, MacKenzie R. Prokaryotic expression of antibodies. Cancer Metastasis Rev. 2005;24(4):501\u201319. https:\/\/doi.org\/10.1007\/s10555-005-6193-1.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"1165_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0168-1656(99)00228-x","volume":"78","author":"LGJ Frenken","year":"2000","unstructured":"Frenken LGJ, van der Linden RHJ, Hermans PWJJ, Bos JW, Ruuls RC, de Geus B, et al. Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J Biotechnol. 2000;78(1):11\u201321. https:\/\/doi.org\/10.1016\/s0168-1656(99)00228-x.","journal-title":"J Biotechnol"},{"issue":"5","key":"1165_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.molimm.2005.03.003","volume":"43","author":"F Rahbarizadeh","year":"2006","unstructured":"Rahbarizadeh F, Rasaee MJ, Forouzandeh M, Allameh A-A. Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris. Mol Immunol. 2006;43(5):426\u201335. https:\/\/doi.org\/10.1016\/j.molimm.2005.03.003.","journal-title":"Mol Immunol"},{"issue":"7","key":"1165_CR20","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.molimm.2006.08.007","volume":"44","author":"N Alvarez-Rueda","year":"2007","unstructured":"Alvarez-Rueda N, Behar G, Ferr\u00e9 V, Pugni\u00e8re M, Roquet F, Gastinel L, et al. Generation of llama single-domain antibodies against methotrexate, a prototypical hapten. Mol Immunol. 2007;44(7):1680\u201390. https:\/\/doi.org\/10.1016\/j.molimm.2006.08.007.","journal-title":"Mol Immunol"},{"issue":"2","key":"1165_CR21","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.ddtec.2010.03.002","volume":"7","author":"JA Kolkman","year":"2010","unstructured":"Kolkman JA, Law DA. Nanobodies \u2013 from llamas to therapeutic proteins. Drug Discov Today Technol. 2010;7(2):e139\u201346. https:\/\/doi.org\/10.1016\/j.ddtec.2010.03.002.","journal-title":"Drug Discov Today Technol"},{"issue":"3","key":"1165_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/1536859041224334","volume":"23","author":"F Rahbarizadeh","year":"2004","unstructured":"Rahbarizadeh F, Rasaee MJ, Forouzandeh Moghadam M, Allameh AA, Sadroddiny E. Production of novel recombinant single-domain antibodies against tandem repeat region of MUC1 mucin. Hybrid Hybridomics. 2004;23(3):151\u201359. https:\/\/doi.org\/10.1089\/1536859041224334.","journal-title":"Hybrid Hybridomics"},{"issue":"5","key":"1165_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.toxicon.2006.11.023","volume":"49","author":"CS Stewart","year":"2007","unstructured":"Stewart CS, MacKenzie CR, Christopher Hall J. Isolation, characterization and pentamerization of \u03b1-cobrotoxin specific single-domain antibodies from a na\u00efve phage display library: preliminary findings for antivenom development. Toxicon. 2007;49(5):699\u2013709. https:\/\/doi.org\/10.1016\/j.toxicon.2006.11.023.","journal-title":"Toxicon"},{"issue":"11","key":"1165_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms19113444","volume":"19","author":"HJ Wagner","year":"2018","unstructured":"Wagner HJ, Wehrle S, Weiss E, Cavallari M, Weber W. A two-step approach for the design and generation of nanobodies. IJMS. 2018;19(11):19. https:\/\/doi.org\/10.3390\/ijms19113444.","journal-title":"IJMS"},{"issue":"3","key":"1165_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00430-009-0116-7","volume":"198","author":"J Wesolowski","year":"2009","unstructured":"Wesolowski J, Alzogaray V, Reyelt J, Unger M, Juarez K, Urrutia M, et al. Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol. 2009;198(3):157\u201374. https:\/\/doi.org\/10.1007\/s00430-009-0116-7.","journal-title":"Med Microbiol Immunol"},{"issue":"17","key":"1165_CR26","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.3390\/ijms20174187","volume":"20","author":"X Cheng","year":"2019","unstructured":"Cheng X, Wang J, Kang G, Hu M, Yuan B, Zhang Y, et al. Homology modeling-based in silico affinity maturation improves the affinity of a nanobody. Int J Mol Sci. 2019;20(17):4187. https:\/\/doi.org\/10.3390\/ijms20174187.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1165_CR27","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1039\/c7cp08116b","volume":"20","author":"MA Soler","year":"2018","unstructured":"Soler MA, Fortuna S, De Marco A, Laio A. Binding affinity prediction of nanobody\u2013protein complexes by scoring of molecular dynamics trajectories. Phys Chem Chem Phys. 2018;20(5):3438\u201344. https:\/\/doi.org\/10.1039\/c7cp08116b.","journal-title":"Phys Chem Chem Phys"},{"key":"1165_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-1-4939-6406-2_16","volume":"1484","author":"K Yugandhar","year":"2017","unstructured":"Yugandhar K, Gromiha MM. Computational approaches for predicting binding partners, interface residues, and binding affinity of protein-protein complexes. Methods Mol Biol. 2017;1484:237\u201353. https:\/\/doi.org\/10.1007\/978-1-4939-6406-2_16.","journal-title":"Methods Mol Biol"},{"issue":"2\u20133","key":"1165_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pbiomolbio.2014.07.004","volume":"116","author":"G Sudha","year":"2014","unstructured":"Sudha G, Nussinov R, Srinivasan N. An overview of recent advances in structural bioinformatics of protein\u2013protein interactions and a guide to their principles. Prog Biophys Mol Biol. 2014;116(2\u20133):141\u201350. https:\/\/doi.org\/10.1016\/j.pbiomolbio.2014.07.004.","journal-title":"Prog Biophys Mol Biol"},{"issue":"W1","key":"1165_CR30","doi-asserted-by":"publisher","first-page":"W469","DOI":"10.1093\/nar\/gkw458","volume":"44","author":"DEV Pires","year":"2016","unstructured":"Pires DEV, Ascher DB. mCSM-AB: a web server for predicting antibody\u2013antigen affinity changes upon mutation with graph-based signatures. Nucleic Acids Res. 2016;44(W1):W469\u201373. https:\/\/doi.org\/10.1093\/nar\/gkw458.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1165_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/pro.2829","volume":"25","author":"S Sirin","year":"2016","unstructured":"Sirin S, Apgar JR, Bennett EM, Keating AE. AB-Bind: antibody binding mutational database for computational affinity predictions. Protein Sci. 2016;25(2):393\u2013409. https:\/\/doi.org\/10.1002\/pro.2829.","journal-title":"Protein Sci"},{"key":"1165_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.01603","volume":"8","author":"P Bannas","year":"2017","unstructured":"Bannas P, Hambach J, Koch-Nolte F. Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics. Front Immunol. 2017;8:1\u201313. https:\/\/doi.org\/10.3389\/fimmu.2017.01603.","journal-title":"Front Immunol"},{"issue":"1","key":"1165_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0168-1656(99)00228-X","volume":"78","author":"LGJ Frenken","year":"2000","unstructured":"Frenken LGJ, Van Der Linden RHJ, Hermans PWJJ, Bos JW, Ruuls RC, De Geus B, et al. Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J Biotechnol. 2000;78(1):11\u201321. https:\/\/doi.org\/10.1016\/S0168-1656(99)00228-X.","journal-title":"J Biotechnol"},{"issue":"1","key":"1165_CR34","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1128\/AEM.71.1.442-450.2005","volume":"71","author":"E Dolk","year":"2005","unstructured":"Dolk E, Van Der Vaart M, Hulsik DL, Vriend G, De Haard H, Spinelli S, et al. Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo. Appl Environ Microbiol. 2005;71(1):442\u201350. https:\/\/doi.org\/10.1128\/AEM.71.1.442-450.2005.","journal-title":"Appl Environ Microbiol"},{"issue":"7873","key":"1165_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583\u201389. https:\/\/doi.org\/10.1038\/s41586-021-03819-2.","journal-title":"Nature"},{"issue":"2","key":"1165_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, et al. The ClusPro web server for protein\u2013protein docking. Nat Protoc. 2017;12(2):255\u201378. https:\/\/doi.org\/10.1038\/nprot.2016.169.","journal-title":"Nat Protoc"},{"issue":"2","key":"1165_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1995","unstructured":"Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions the LIGPLOT program automatically generates schematic 2-D representations of protein-ligand complexes from standard protein data Bank file input. Protein Eng Des Sel. 1995;8(2):127\u201334. https:\/\/doi.org\/10.1093\/protein\/8.2.127.","journal-title":"Protein Eng Des Sel"},{"issue":"23","key":"1165_CR38","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","volume":"32","author":"LC Xue","year":"2016","unstructured":"Xue LC, Rodrigues JP, Kastritis PL, Bonvin AM, Vangone A. PRODIGY: a web server for predicting the binding affinity of protein\u2013protein complexes. Bioinformatics. 2016;32(23):3676\u201378. https:\/\/doi.org\/10.1093\/bioinformatics\/btw514.","journal-title":"Bioinformatics"},{"issue":"1","key":"1165_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33011\/livecoms.1.1.5068","volume":"1","author":"J Lemkul","year":"2018","unstructured":"Lemkul J. From proteins to perturbed hamiltonians: a suite of tutorials for the GROMACS-2018 molecular simulation package [Article v1.0]. Living J Comp Mol Sci. 2018;1(1):1\u201353. https:\/\/doi.org\/10.33011\/livecoms.1.1.5068.","journal-title":"Living J Comp Mol Sci"},{"issue":"16","key":"1165_CR40","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26(16):1701\u201318. https:\/\/doi.org\/10.1002\/jcc.20291.","journal-title":"J Comput Chem"},{"issue":"2","key":"1165_CR41","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79(2):926\u201335. https:\/\/doi.org\/10.1063\/1.445869.","journal-title":"J Chem Phys"},{"issue":"9","key":"1165_CR42","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1063\/1.470043","volume":"103","author":"HG Petersen","year":"1995","unstructured":"Petersen HG. Accuracy and efficiency of the particle mesh Ewald method. J Chem Phys. 1995;103(9):3668\u201379. https:\/\/doi.org\/10.1063\/1.470043.","journal-title":"J Chem Phys"},{"issue":"1","key":"1165_CR43","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF02192649","volume":"89","author":"KC Kiwiel","year":"1996","unstructured":"Kiwiel KC, Murty K. Convergence of the steepest descent method for minimizing quasiconvex functions. J Optim Theory Appl. 1996;89(1):221\u201326. https:\/\/doi.org\/10.1007\/BF02192649.","journal-title":"J Optim Theory Appl"},{"issue":"12","key":"1165_CR44","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello M, Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys. 1981;52(12):7182\u201390. https:\/\/doi.org\/10.1063\/1.328693.","journal-title":"J Appl Phys"},{"issue":"10","key":"1165_CR45","doi-asserted-by":"publisher","first-page":"8345","DOI":"10.1063\/1.465608","volume":"99","author":"DM York","year":"1993","unstructured":"York DM, Darden TA, Pedersen LG. The effect of long-range electrostatic interactions in simulations of macromolecular crystals: a comparison of the Ewald and truncated list methods. J Chem Phys. 1993;99(10):8345\u201348. https:\/\/doi.org\/10.1063\/1.465608.","journal-title":"J Chem Phys"},{"issue":"12","key":"1165_CR46","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. LINCS: a linear constraint solver for molecular simulations. J Comput Chem. 1997;18(12):1463\u201372. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199709)18:12%253C1463::AID-JCC4%253E3.0.CO;2-H.","journal-title":"J Comput Chem"},{"key":"1165_CR47","unstructured":"Nanome Inc. Nanome: creating powerful, collaborative and scientific vr tools. San Diego, CA; 2020. https:\/\/nanome.ai."},{"issue":"4","key":"1165_CR48","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1021\/jp9110794","volume":"114","author":"JA Lemkul","year":"2010","unstructured":"Lemkul JA, Bevan DR. Assessing the stability of Alzheimer\u2019s amyloid protofibrils using molecular dynamics. J Phys Chem. B. 2010;114(4):1652\u201360. https:\/\/doi.org\/10.1021\/jp9110794.","journal-title":"The J Phys Chem. B"},{"issue":"2","key":"1165_CR49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0021-9991(77)90121-8","volume":"23","author":"GM Torrie","year":"1977","unstructured":"Torrie GM, Valleau JP. Nonphysical sampling distributions in Monte Carlo free-energy estimation: umbrella sampling. J Comput Phys. 1977;23(2):187\u201399. https:\/\/doi.org\/10.1016\/0021-9991(77)90121-8.","journal-title":"J Comput Phys"},{"issue":"12","key":"1165_CR50","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1021\/ct100494z","volume":"6","author":"JS Hub","year":"2010","unstructured":"Hub JS, De Groot BL, Van Der Spoel D. g_wham\u2014A free weighted histogram analysis implementation including robust error and autocorrelation estimates. J Chem Theory Comput. 2010;6(12):3713\u201320. https:\/\/doi.org\/10.1021\/ct100494z.","journal-title":"J Chem Theory Comput"},{"issue":"2","key":"1165_CR51","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1021\/acs.jctc.7b00660","volume":"14","author":"JS Patel","year":"2018","unstructured":"Patel JS, Ytreberg FM. Fast calculation of protein\u2013protein binding free energies using umbrella sampling with a coarse-grained model. J Chem Theory Comput. 2018;14(2):991\u201397. https:\/\/doi.org\/10.1021\/acs.jctc.7b00660.","journal-title":"J Chem Theory Comput"},{"issue":"1","key":"1165_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14(1):33\u201338; December 1995: 33-8.https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5.","journal-title":"J Mol Graph"},{"key":"1165_CR53","unstructured":"The PyMOL Molecular Graphics System. Version 3.0. Schr\u00f6dinger, LLC. https:\/\/www.pymol.org."},{"key":"1165_CR54","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.pep.2021.105906","volume":"185","author":"CK Kariuki","year":"2021","unstructured":"Kariuki CK, Magez S. Improving the yield of recalcitrant Nanobodies \u00ae by simple modifications to the standard protocol. Protein Exp Purif. 2021;185:105906. https:\/\/doi.org\/10.1016\/j.pep.2021.105906.","journal-title":"Protein Exp Purif"},{"issue":"3","key":"1165_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0173778","volume":"12","author":"M Teodorowicz","year":"2017","unstructured":"Teodorowicz M, Perdijk O, Verhoek I, Govers C, Savelkoul F, Tang Y, et al. Optimized Triton X-114 assisted lipopolysaccharide (LPS) removal method reveals the immunomodulatory effect of food proteins. PLoS One. 2017;12(3):1\u201319. https:\/\/doi.org\/10.1371\/journal.pone.0173778.","journal-title":"PLoS One"},{"key":"1165_CR56","unstructured":"European Medicines Agency. Assessment report. 2020. Amsterdam, The Netherlands."},{"issue":"1","key":"1165_CR57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1(1):27\u201330. https:\/\/doi.org\/10.1038\/nm0195-27.","journal-title":"Nat Med"},{"issue":"1","key":"1165_CR58","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/dta.2693","volume":"12","author":"A Sadeghi","year":"2020","unstructured":"Sadeghi A, Behdani M, Muyldermans S, Habibi-Anbouhi M, Kazemi-Lomedasht F. Development of a mono-specific anti-VEGF bivalent nanobody with extended plasma half-life for treatment of pathologic neovascularization. Drug Test Anal. 2020;12(1):92\u2013100. https:\/\/doi.org\/10.1002\/dta.2693.","journal-title":"Drug Test Anal"},{"issue":"6","key":"1165_CR59","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1080\/08830185.2018.1526932","volume":"37","author":"F Khodabakhsh","year":"2018","unstructured":"Khodabakhsh F, Behdani M, Rami A, Kazemi-Lomedasht F. Single-domain antibodies or nanobodies: a class of next-generation antibodies. Int Rev Immunol. 2018;37(6):316\u201322. https:\/\/doi.org\/10.1080\/08830185.2018.1526932.","journal-title":"Int Rev Immunol"},{"key":"1165_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sbi.2015.01.001","volume":"32","author":"A Desmyter","year":"2015","unstructured":"Desmyter A, Spinelli S, Roussel A, Cambillau C. Camelid nanobodies: killing two birds with one stone. Curr Opin Struct Biol. 2015;32:1\u20138. https:\/\/doi.org\/10.1016\/j.sbi.2015.01.001.","journal-title":"Curr Opin Struct Biol"},{"key":"1165_CR61","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.2147\/IJN.S39428","volume":"8","author":"CG Siontorou","year":"2013","unstructured":"Siontorou CG. Nanobodies as novel agents for disease diagnosis and therapy. Int J Nanomed. 2013;8:4215\u201327. https:\/\/doi.org\/10.2147\/IJN.S39428.","journal-title":"Int J Nanomed"},{"issue":"4","key":"1165_CR62","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/intimm\/dxx077","volume":"30","author":"T Yamashita","year":"2018","unstructured":"Yamashita T. Toward rational antibody design: recent advancements in molecular dynamics simulations. Int Immunol. 2018;30(4):133\u201340. https:\/\/doi.org\/10.1093\/intimm\/dxx077.","journal-title":"Int Immunol"},{"issue":"9","key":"1165_CR63","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/protein\/gzaa006","volume":"32","author":"H Akiba","year":"2019","unstructured":"Akiba H, Tamura H, Caaveiro JMM, Tsumoto K. Computer-guided library generation applied to the optimization of single-domain antibodies. Protein Eng Des Sel. 2019;32(9):423\u201331. https:\/\/doi.org\/10.1093\/protein\/gzaa006.","journal-title":"Protein Eng Des Sel"},{"key":"1165_CR64","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ijbiomac.2020.02.180","volume":"151","author":"X Wang","year":"2020","unstructured":"Wang X, Chen Q, Sun Z, Wang Y, Su B, Zhang C, et al. Nanobody affinity improvement: directed evolution of the anti-ochratoxin a single domain antibody. Int J Biol Macromol. 2020;151:312\u201321. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.02.180.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"1165_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-22111-4","volume":"8","author":"Z Wang","year":"2018","unstructured":"Wang Z, Li Y, Liang W, Zheng J, Li S, Hu C, et al. A highly sensitive detection system based on proximity-dependent hybridization with computer-aided affinity maturation of a scFv antibody. Sci Rep. 2018;8(1):1\u201312. https:\/\/doi.org\/10.1038\/s41598-018-22111-4.","journal-title":"Sci Rep"},{"issue":"5","key":"1165_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pcbi.1006980","volume":"15","author":"DA Cannon","year":"2019","unstructured":"Cannon DA, Shan L, Du Q, Shirinian L, Rickert KW, Rosenthal KL, et al. Experimentally guided computational antibody affinity maturation with de novo docking, modelling and rational design. PLoS Comput Biol. 2019;15(5):1\u201322. https:\/\/doi.org\/10.1371\/journal.pcbi.1006980.","journal-title":"PLoS Comput Biol"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-026-01165-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01165-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01165-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:10:56Z","timestamp":1783354256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12896-026-01165-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1186\/s12896-026-01165-7","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No human studies were conducted in this research, and human RPE cells, as refered in the manuscript, were obtained from the Central Eye Bank of Iran and was approved by the Institutional Review Board of the Central Eye Bank of Iran and the ethics committee of the Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, affiliated with Shahid Beheshti University of Medical Sciences (Tehran, Iran).The research was ethically reviewed and approved by the ethical committee of the Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences (IR.SBMU.ORC.REC.1401.001), and the ethical committee of the Pasteur Institute of Iran (IR.PII.AEC.1401.001), as a PhD thesis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"During the preparation of this work, the authors used Perplexity AI in order to improve the readability and language of the manuscript. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI statement"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}